When a company posts earnings, the reports are intensely examined by investors and analysts alike. Earnings are important because they can give insight into the profitability of a company. Covering Street analysts are looking for Orexigen Therapeutics, Inc. (NASDAQ:OREX) to report quarterly EPS of $-0.15. The company is next expected to publish earnings on or around 2016-08-04 for the period ending 2016-06-30. In the same quarter last year, the company posted EPS of $-0.18. The company most recently posted quarterly earnings per share of $-0.15. Leading up to the earnings report, the Zacks Research consensus using polled analysts was $-0.1. The gap in the numbers was $-0.05 which created a surprise factor of -50%. Surprise factors are important to view as a company releases earnings. Surprise factors may create significant stock price movements after the release.
Covering analysts often adjust projections before and after the earnings period. Presently, analysts polled by Zacks Research have a mean target price of $1.025 on shares. This target is including 4 different analysts taken into consideration by Zacks Research. Analyst standpoints may vary on where they anticipate the stock heading in the future. Out of all the polled analysts, the most bullish estimate has the stock hitting 2 in the next year. The analyst with the low end target price views shares going to $0.5 within the same period. Zacks Research compiles analyst ratings using a scale that spans from 1 to 5. If the company has a ratings score of 1, this would indicate a Strong Buy. If the company has a 5 rating, this would signify a Strong Sell. Combining all the ratings on Orexigen Therapeutics, Inc. (NASDAQ:OREX), the present mean is sitting at 3.2.
